Small human comparisons exist
Selank for anxiety
Russian groups compared Selank with older sedatives in people with anxiety disorders. The abstracts report anxiety outcomes but never state a human dose.
Open the Selank evidence guidePage last checked
Goal
Selank is the only peptide on this site with published human anxiety studies. None of those abstracts states how much participants received.
Source: Based on 2 compound guides · checked 2026-08-13
That gives Selank real human evidence, but no usable dose. The studies were small, written in Russian and never registered in a trial database. Their abstracts report anxiety scores, but not the amount given.
Semax is often compared with Selank in the same search. Its human studies followed stroke, motor-neuron disease and brain injury instead. BPC-157 has no human anxiety study. Depression has no direct comparison among any of the three.
Compounds covered
2
With published human dosing
1 of 2
Approved or being tested for this
0
No human evidence for this goal
1
Start with the outcome
Anxiety treatment, depression, peptide comparisons and GLP-1 safety are different questions. Choose the one that matches what you want to know.
Small human comparisons exist
Russian groups compared Selank with older sedatives in people with anxiety disorders. The abstracts report anxiety outcomes but never state a human dose.
Open the Selank evidence guideNo peptide ranks first
These peptide records do not establish a best anxiety treatment. If the question began after a GLP-1, that is a separate class-safety question with its own FDA timeline.
Read the separate GLP-1 safety evidenceNo depression comparison
The two have never been compared for depression. Selank’s human papers studied anxiety disorders; Semax’s human papers studied neurologic recovery and motor-neuron disease.
See what Semax was actually studied forNo human anxiety study
BPC-157’s small human reports covered knee pain, bladder symptoms and an infusion safety pilot. None measured anxiety or depression.
Open the BPC-157 human evidenceSelank has studies in anxiety. Semax has more human studies, but in different neurologic conditions. Neither supports a depression comparison.
| Compound | What people take it for | What research shows | Evidence |
|---|---|---|---|
| Selank | People buy it for anxiety, stress and calm focus, often as a nasal product and sometimes as powder for injection.Measured in a human study | Russian groups studied it in people with generalized anxiety, phobic anxiety and related disorders. The reports include active comparisons, but none of the reachable abstracts prints the amount anyone received. No trial was registered, and the human safety profile repeated in English reviews traces to a rat experiment. | limited human dataNo human dose published |
| Semax | People buy it as a nootropic for focus and memory, then compare it with Selank when searching for mood or depression support.Reported use only | Its human papers studied recovery after stroke, motor-neuron disease and oxygen-starvation brain injury. None measured anxiety or depression. The clearest result was negative in 27 people with motor-neuron disease, and the published quantities belong to nasal use rather than an injection under the skin. | limited human dataDose from a human trial · no FDA label |
That combination matters. Sixty-two people with generalized anxiety disorder or neurasthenia were compared across Selank and medazepam groups. Another 60 with phobic-anxiety or somatoform disorders were compared with phenazepam, and a later 70-person study used Selank as an add-on. Those are human anxiety studies, not cell or animal work.
The reachable abstracts still leave out the amount given. No registration supplies the missing protocol because no Selank study appears on a trial registry. A page can report the outcome and still refuse to invent the dose; here it has to do both.
The safety claims are thinner than the benefit claims. English reviews describe a reassuring human side-effect profile, but their cited source is a rat study. That does not prove the opposite. It means the human safety claim has no human source behind it.
No paper on either record compares Semax with Selank for depression. Selank’s studies enrolled people with anxiety-related diagnoses. Semax’s studies enrolled people with neurologic injury or disease. Putting the names in one search does not put them in one trial.
BPC-157 does not close the gap. Its small human reports did not measure anxiety, mood or depression, and almost all published research on it remains animal work. The available studies cannot rank any of these three as a depression treatment.
The 10 goal categories, side by side
Selank without an approved label: what exists instead
Semax without an approved label: what exists instead
What is established for testosterone
Skin: the page beside the pitch
Where the sexual function evidence stops
Every compound sold for healing and recovery
The sleep table, basis by basis